Table 4.
Relationship between intratumoral ALDH1 expression and clinicopathological parameters of invasive breast cancer
| Variables | Intratumoral ALDH1 | ||
|---|---|---|---|
| Negative | Positive | P value | |
| Age (y) | |||
| ≤50 | 23 | 41 | 0.243 |
| >50 | 14 | 40 | |
| Tumor size | |||
| ≤2 cm | 24 | 30 | 0.001 |
| >2 cm | 10 | 53 | |
| Grade | |||
| I-II | 27 | 36 | <0.001 |
| III | 4 | 35 | |
| Axillary node status | |||
| Negative | 22 | 38 | 0.156 |
| Positive | 14 | 43 | |
| ER status | |||
| Negative | 11 | 28 | 0.604 |
| Positive | 26 | 53 | |
| Her2 status | |||
| Negative | 28 | 63 | 0.801 |
| Positive | 9 | 18 | |
| Ki67 | |||
| ≤14 % | 15 | 21 | 0.009 |
| >14 % | 12 | 55 | |
| Molecular subtype | |||
| Triple negative | 6 | 17 | 0.992 |
| Non-triple negative | 22 | 62 | |